U.S. Personal Products Stock News

In early June 2026, GitLab Inc. reported first-quarter fiscal 2027 results showing revenue of US$264.16 million and a net loss of US$4.97 million, alongside new guidance calling for second-quarter revenue of US$272 million–US$274 million and full-year revenue of US$1.11 billion–US$1.12 billion. At the same time, GitLab completed a US$50.05 million share repurchase and announced an “Act Two” restructuring to cut about 14% of staff and reinvest savings into its AI-driven Duo Agent Platform and...

Exelixis reported new phase 3 CABINET trial data for CABOMETYX in advanced neuroendocrine tumors. The subgroup analysis showed significant improvements in progression free survival regardless of tumor functional status. These data were presented at ASCO 2026 and expand the evidence base for CABOMETYX in neuroendocrine tumors. For investors following NasdaqGS:EXEL, the CABINET subgroup results arrive with the stock at $52.7 and strong recent returns, including 20.9% year to date and 22.5%...

Recent stock performance and business context Arcus Biosciences (RCUS) has drawn attention after recent share price moves, with the stock down 6.1% on the day and about 10.8% over the past month, while still up over the past 3 months. At a recent close of US$23.19 and a market value of around US$3.1b, the company remains a clinical stage cancer therapy developer with revenue of US$236.0m and a reported net loss of US$369.0m. See our latest analysis for Arcus Biosciences. Recent moves have...

Zeta Global Holdings (ZETA) is back in focus after its latest earnings report, where revenue grew 49.9% year on year, beat expectations by 7%, and the company raised full year guidance more than its peers. See our latest analysis for Zeta Global Holdings. At a share price of $22.02, Zeta Global’s 30 day share price return of 27.8% and 1 year total shareholder return of 58.3% suggest momentum has picked up recently despite a softer 7 day patch. If strong software earnings have your attention,...

Recently, Zacks Investment Research upgraded Sharplink Inc. (SBET) to a Rank #2 (Buy), citing an upward trend in the company’s earnings estimates. This reassessment of Sharplink’s earnings outlook highlights how revisions in expectations can influence investor perception of the business’s longer-term potential. Next, we’ll explore how this improved earnings outlook, reflected in the Zacks upgrade, shapes Sharplink’s broader investment narrative. Invest in the nuclear renaissance through our...

Fresh Del Monte Produce (FDP) is in focus after its Del Monte Foods division announced a multi-year partnership with the Pittsburgh Pirates, while also naming Pittsburgh as the operational hub for its Foods Division. See our latest analysis for Fresh Del Monte Produce. The new Pittsburgh partnership comes after a tougher stretch for the stock, with the 30 day share price return down 21.28% and the 90 day share price return down 30.70%. The three year total shareholder return sits at 21.86%,...

Recent performance context for Blue Bird Without a single headline event driving attention, Blue Bird (BLBD) has still been on many investors’ radar after recent share price moves and solid reported figures for revenue, net income and returns. See our latest analysis for Blue Bird. At a share price of US$71.95, Blue Bird’s recent 30-day share price return of 13.50% and year to date share price return of 53.87% sit alongside a 1-year total shareholder return of 78.54%. This suggests momentum...

Apollo Global Management has recently deepened its role in the AI infrastructure build-out through a planned US$35.00 billion AI compute platform with Broadcom, while also advancing logistics real estate fundraising and completing new private equity transactions. At the same time, Apollo is reinforcing its differentiated model that pairs retirement-focused capital from Athene with large-scale alternative investments, while facing fresh regulatory and valuation scrutiny around private credit...

Uranium Energy recently benefited from Urenco’s decision to expand uranium enrichment capacity at the only commercial U.S. facility, combined with U.S. moves to phase out Russian uranium imports by 2028 and rising nuclear power interest tied to AI-driven electricity demand. This combination of domestic enrichment growth, geopolitical supply shifts and data-center energy needs highlights how policy and technology trends can reshape uranium miners’ long-term commercial opportunities. We’ll now...

Paramount Skydance's acquisition of Warner Bros. Discovery (NasdaqGS:WBD) is moving through global regulatory reviews, including a formal process in Europe. U.S. attorneys general are examining potential competition and industry impacts from the proposed Hollywood combination. Warner Bros. Discovery has reported a profitable streaming segment and recorded a substantial, one off merger related fee that resulted in a large loss. Warner Bros. Discovery, the media and entertainment group behind...

In early June 2026, Signet Jewelers reported first-quarter Fiscal 2027 results with modest revenue growth to US$1,553.6 million, slightly lower net income of US$31.7 million, raised full-year sales and earnings guidance, declared a US$0.35 quarterly dividend for August 21, 2026, and continued returning capital via share repurchases including a new US$50 million accelerated program. These updates highlight management’s confidence in its Grow Brand Love restructuring, as positive same-store...

What is moving Antero Resources stock now? Antero Resources (AR) has drawn fresh attention after recent trading, with the stock closing at US$35.56. Investors are weighing that price against the company’s reported US$5.63b in revenue and US$961.66m in net income. See our latest analysis for Antero Resources. Recent trading has been choppy, with the 1-day share price return down 4.15% and the 90-day share price return down 8.42%, even though the year-to-date share price return is up 3.95%...

With inflation pressures tied to energy and freight, shifting central bank policies, and uneven growth across regions, many investors are looking beyond the usual large cap stocks. That is where the High-Quality Undiscovered Gems screener comes in. It focuses on smaller companies with solid fundamentals that are less crowded by big funds. By targeting stocks that are not heavily owned by institutions, you are not just following the usual playbook; you are looking where others are not paying...

Why Cimpress stock is catching investor attention Cimpress (CMPR) has drawn fresh interest after a period of mixed share performance, with the stock down over the past week but higher over the month and past 3 months. That recent pattern, together with a one year total return above 100% and a market value of about US$2.35b, is encouraging some investors to take a closer look at how the printing and mass customization business is positioned. See our latest analysis for Cimpress. Short term,...

Wondering whether NVR at around US$6,182 per share is offering fair value or an opportunity? This article looks at what the current price really reflects. The stock has edged up 1.3% over the past week and 1.4% over the past month, yet is still down 15.1% year to date and 13.1% over the last year. This naturally raises questions about how the market is assessing its prospects and risks. Recent attention on NVR has focused on its broader sector context and housing market conditions, with...

Applied Digital stock in focus Applied Digital (APLD) has drawn fresh attention after recent share price volatility, with the stock down 10% over the past month but still showing a very large total return over the past year. See our latest analysis for Applied Digital. Recent share price moves have been choppy, with the stock falling 10.26% over the last day and 16.20% over the week. However, the 1 year total shareholder return of 185.86% and the very large 3 year total shareholder return...

Griffon stock snapshot Griffon (GFF) has caught investor attention after recent trading left the stock at a last close of US$85.50, with short term returns mixed and longer term performance data pointing to very different outcomes. See our latest analysis for Griffon. Recent trading has been choppy, with the share price down 7.65% over the past month but still showing a 13.94% year to date share price return and a 5 year total shareholder return of 309.16%. This points to momentum that has...

In recent days, Waste Connections has come under scrutiny as commentary highlighted slowing demand, shrinking free cash flow margins, and below-average returns on capital that point to weaker investment opportunities. This shift suggests that some of the company’s traditional profit engines may be losing strength, prompting investors to reassess the resilience of its business model. Next, we’ll examine how concerns about shrinking free cash flow margins may reshape Waste Connections’...

PENN Entertainment (NasdaqGS:PENN) is opening the new US$360 million Hollywood Casino Aurora as its latest land-based flagship in Illinois. The long-running Hollywood Casino riverboat in Aurora is set to close after more than 30 years of operation as activity shifts to the new property. The new complex combines gaming, hotel rooms, dining, and entertainment offerings in a single, purpose-built facility. The move reflects PENN Entertainment's push to grow its brick and mortar footprint...

If you are wondering whether Reddit's share price lines up with its underlying value or if sentiment has run ahead of the story, this breakdown walks through what the current price might actually be implying. Reddit closed at US$173.45, with the stock down 1.4% over the last week, up 4.1% over the last month, down 28.3% year to date and up 43.0% over the last year, which points to shifting views on both its growth potential and its risk profile. Recent headlines have focused on Reddit's role...

Madrigal Pharmaceuticals (MDGL) is back in focus after new Phase 3 and real world data presented at the EASL Congress 2026 linked its MASH drug Rezdiffra to improved liver and cardiovascular risk markers. See our latest analysis for Madrigal Pharmaceuticals. Despite a recent pullback, including a 7 day share price return of down 4.5% and some profit taking after insider sales, Madrigal’s 1 year total shareholder return of about 80% and 5 year total shareholder return of over 3.5x suggest...

KKR (NYSE:KKR) is reported to be among the leading bidders for a significant minority stake in Cloudnine, an Indian maternity and pediatric hospital chain. The potential transaction could value Cloudnine at about US$1b. If completed, the deal would represent a sizable healthcare-related investment for KKR in an emerging market. Cloudnine is described as India's largest maternity and pediatric hospital chain. This potential investment would give KKR exposure to specialized healthcare...

If you are wondering whether AllianceBernstein Holding at around US$37.19 is attractively priced or asking too much for future returns, the starting point is understanding what the current valuation is actually baking in. The stock has been relatively steady over the past week with a 0.5% gain, while it has fallen 7.8% over the last month, is down 3.8% year to date, yet still shows a 2.4% return over one year, 39.4% over three years and 24.1% over five years. Recent coverage has focused on...

In late May 2026, The Clorox Company announced that Chair and CEO Linda Rendle will step down for health reasons, with a comprehensive board-led search underway while she remains in place and then transitions to an advisory role to support continuity. This planned leadership change comes as Clorox is working through operational and demand challenges, making succession decisions particularly important for the company’s direction. We’ll examine how Rendle’s planned departure and the board’s...